Literature DB >> 19962042

Particle size of inhaled corticosteroids: does it matter?

Chet Leach1, Gene L Colice, Allan Luskin.   

Abstract

A question with respect to asthma therapy revolves around the issue of whether better efficacy occurs with an ultrafine-particle inhaled corticosteroid because of better lung deposition into the distal airways. This article reviews particle size and delivery devices of different steroids, clinical outcomes of small- versus large-particle steroids, and the issue of pharmacoeconomics.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19962042     DOI： 10.1016/j.jaci.2009.09.050

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


  18 in total

1.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

2.  Initial observations of cell-mediated drug delivery to the deep lung.

Authors:  Arun Kumar; Mark Glaum; Nagwa El-Badri; Shyam Mohapatra; Edward Haller; Seungjoo Park; Leslie Patrick; Leigh Nattkemper; Dawn Vo; Don F Cameron
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

3.  Ideal Particle Sizes for Inhaled Steroids Targeting Vocal Granulomas: Preliminary Study Using Computational Fluid Dynamics.

Authors:  Elizabeth L Perkins; Saikat Basu; Guilherme J M Garcia; Robert A Buckmire; Rupali N Shah; Julia S Kimbell
Journal:  Otolaryngol Head Neck Surg       Date:  2017-11-21       Impact factor: 3.497

4.  Comparison of the efficacy of ciclesonide with that of budesonide in mild to moderate asthma patients after step-down therapy: a randomised parallel-group study.

Authors:  Kuo-Chin Chiu; Yen-Li Chou; Jeng-Yuan Hsu; Ming-Shian Lin; Ching-Hsiung Lin; Pai-Chien Chou; Chun-Liang Chou; Chun-Hua Wang; Han-Pin Kuo
Journal:  NPJ Prim Care Respir Med       Date:  2014-05-20       Impact factor: 2.871

5.  Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.

Authors:  Richard J Martin; David Price; Nicolas Roche; Elliot Israel; Willem M C van Aalderen; Jonathan Grigg; Dirkje S Postma; Theresa W Guilbert; Elizabeth V Hillyer; Anne Burden; Julie von Ziegenweidt; Gene Colice
Journal:  NPJ Prim Care Respir Med       Date:  2014-10-09       Impact factor: 2.871

6.  Extrafine inhaled corticosteroid therapy in the control of asthma.

Authors:  István Ivancsó; Renáta Böcskei; Veronika Müller; Lilla Tamási
Journal:  J Asthma Allergy       Date:  2013-06-06

7.  From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids.

Authors:  Ruediger Nave; Helgert Mueller
Journal:  Int J Gen Med       Date:  2013-03-07

Review 8.  Integrating evidence for managing asthma in patients who smoke.

Authors:  David Price; Leif Bjermer; Todor A Popov; Alison Chisholm
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-17       Impact factor: 5.764

Review 9.  Recent advances in understanding and managing asthma.

Authors:  Su-Ling Loo; Peter A B Wark
Journal:  F1000Res       Date:  2016-08-23

Review 10.  Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.

Authors:  Brian J Clouse; Sudarshan R Jadcherla; Jonathan L Slaughter
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.